武汉大学人民医院湖北省人民医院

院内导航

邢怡桥 眼科学
主任医师，教授，博士生导师

A+ A-

导师介绍

姓名	邢怡桥
出生年月	1957年11月
单位	武汉大学人民医院眼科
所属学科	临床医学-眼科学
职务、职称及头衔	主任医师，教授，博士生导师
E-mail	yiqiao_xing57@whu.edu.cn
联系方式	027-88041911-82038, 13707111541
研究方向	1.玻璃体视网膜(基础/临床)2 .白内障
个人简介	主要从事玻璃体视网膜、白内障领域的研究及临床工作。先后主持承担国家自然科学基金面上项目3项、国家“十一五”支撑计划项目、国家“十五”攻关项目及省级重大项目重点项目、省自然科学基金，参与国家重点基础研究发展计划973计划等20余项；主持完成的科研课题获湖北省科技进步二等奖1项、湖北省科技进步三等奖1项；“华夏医学科技奖”三等奖等。主编学术专著6部，副主编2部，其中主编德文专著1部曾被德国国家图书馆收藏；在国内外学术期刊发表、指导发表SCI 120余篇，其中为第一作者或通讯作者50余篇。
学术任职与荣誉	武汉大学附属爱尔眼科医院及武汉大学人民医院主任医师、教授，博士生导师。担任爱尔眼科集团湖北省区和河南省区总院长。担任中华医学会专家会员、湖北省眼底病学组组长、湖北省医师协会眼科医师分会名誉主任委员、湖北省眼科医疗质量控制中心名誉主任和国家自然科学基金评审专家等。担任《中华眼科杂志》、《中华眼底病杂志》、《中华实验眼科杂志》等眼科专业杂志编委以及教育部学位中心学位论文评审专家。 2010-2012年创先争优秀党员年（湖北省卫生厅授予），湖北省首届“百佳医生”，2012年亚洲防基金会授予先进个人，2013年获第四届中国眼科医师奖，2007获中华眼科学会奖。
教育履历	1978.03－1982.12湖北医学院（现武汉大学医学部）临床医学系获学士学位 1986.09－1989.07湖北医学院（现武汉大学医学部）获硕士学位 1994.04－1996.10马尔堡菲利普大学获博士学位
工作履历	1982.12--1986.09武汉大学人民医院眼科住院医师 1986.09－1994.04武汉大学人民医院眼科主治医师 1996.10－2001.09武汉大学人民医院眼科副主任医师、副教授 2001.09－2002.09武汉大学人民医院眼科主任医师 2002－至今武汉大学人民医院眼科教授 2004.01－至今武汉大学人民医院博士生导师
成果获奖	1.“华夏医学科技奖”三等奖 2.曲安奈德在玻璃体视网膜疾病中应用研究. 湖北省科技进步二等奖 3.早产儿视网膜病变基础与临床研究. 获湖北省科技进步三等奖. 4.湖北省优秀博士生论文指导教师
代表性论著	1.Zeng S, Du L, Lu G, Xing Y. CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway [published online ahead of print, 2023 Jul 4]. Mol Neurobiol. 2023;10.1007/s12035-023-03466-w. doi:10.1007/s12035-023-03466-w 2.Yang N, Zhang N, Wang Z, Cao W, He X, Zhang W, Xing Y. Galectin-1-dependent ceRNA network in HRMECs revealed its association with retinal neovascularization. BMC Genomics. 2023;24(1):327. Published 2023 Jun 15. doi:10.1186/s12864-023-09352-y 3.He X, Cao W, Wang Z, Zhang N, Xu K, Yu L, Xing Y, Yang N. Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis. J Clin Med. 2023;12(3):1035. Published 2023 Jan 29. doi:10.3390/jcm12031035 4.Yang W, Yang K, Pan Y, Wu S, Chen X, Shen L, Zeng Q, Wu J, Lv M, Zhang Jm Yang Y, Xing Y. A literature-derived dataset on risk factors for dry eye disease. Sci Data. 2023;10(1):21. Published 2023 Jan 11. doi:10.1038/s41597-023-01931-8 5. Guo X, Xing Y, Jin W*. Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2023;14:1183586. Published 2023 Apr 21. doi:10.3389/fendo.2023.1183586

Name	YIQIAO XING
Date of birth	November,1957
Department	Ophthalmology Department, Renmin Hospital, Wuhan University.
Title	Director, Professor, doctoral tutor
Email	yiqiao_xing57@whu.edu.cn
TEL	027-88041911-82038, 13707111541
Research Direction	1. Vitreoretinal Diseases (Basic/Clinic) 2. Cataract
Personal Profile	Professor Xing is mainly engaging in the field of vitreoretinal and cataract research and clinical work. To host the National Natural Science Foundation project, public welfare industry research project, China’s National Tenth Five-Year and Eleventh Five-Year Plan support project, key project of provincial project and Provincial Natural Science Fund, to participate in more than 20 key research items, including National Key Basic Research and Development Plan——973 Plan. The research projects he presided over won 1 second prize of Science and Technology Progress of Hubei Province and 1 third prize of science and Technology Progress of Hubei Province; "Huaxia Medical Science and Technology Award" third prize. He has 6 academic monographs of editor in chief and 2 associate editor’s academic monographs. One German monographs was collected by the German National Library.To publish more than 120 SCI papers in academic journals at domestic and overseas, of which more than 50 are the first author or corresponding author.
Selected Publications	1.Zeng S, Du L, Lu G, Xing Y. CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway [published online ahead of print, 2023 Jul 4]. Mol Neurobiol. 2023;10.1007/s12035-023-03466-w. doi:10.1007/s12035-023-03466-w 2.Yang N, Zhang N, Wang Z, Cao W, He X, Zhang W, Xing Y. Galectin-1-dependent ceRNA network in HRMECs revealed its association with retinal neovascularization. BMC Genomics. 2023;24(1):327. Published 2023 Jun 15. doi:10.1186/s12864-023-09352-y 3.He X, Cao W, Wang Z, Zhang N, Xu K, Yu L, Xing Y, Yang N. Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis. J Clin Med. 2023;12(3):1035. Published 2023 Jan 29. doi:10.3390/jcm12031035 4.Yang W, Yang K, Pan Y, Wu S, Chen X, Shen L, Zeng Q, Wu J, Lv M, Zhang Jm Yang Y, Xing Y. A literature-derived dataset on risk factors for dry eye disease. Sci Data. 2023;10(1):21. Published 2023 Jan 11. doi:10.1038/s41597-023-01931-8 5. Guo X, Xing Y, Jin W*. Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2023;14:1183586. Published 2023 Apr 21. doi:10.3389/fendo.2023.1183586